Related Experiment Video

Updated: Aug 18, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Statins and cholesterol lowering after a cancer diagnosis: why not?

Mark A Moyad1, Gregory S Merrick

  • 1Phil F. Jenkins Director of Complementary & Alternative Medicine, Department of Urology, University of Michigan Medical Center, Ann Arbor, 48109-0330, USA. moyad@umich.edu

Urologic Oncology
|May 12, 2005
PubMed

Insights

Statins show promise in inhibiting cancer cell growth and may benefit prostate cancer patients. Further clinical trials are warranted to explore their use as adjuvant therapy or monotherapy.

Area of Science:

  • Cardiovascular Pharmacology
  • Oncology
  • Drug Repurposing

Background:

  • Statins exhibit pleiotropic effects, with growing interest in their anticancer properties.
  • Existing research indicates statins can inhibit various cancer cell lines and potentially synergize with conventional treatments.

Purpose of the Study:

  • To evaluate the potential of statins as an intervention for numerous cancers, with a specific focus on prostate cancer.
  • To explore statins as a therapeutic option for prostate cancer, considering its unique treatment landscape and the high prevalence of cardiovascular disease in affected men.

Main Methods:

  • Review of existing laboratory and preliminary clinical data on statins' effects on cancer.
  • Consideration of prostate cancer patient characteristics, including watchful waiting for well-differentiated tumors and co-existing cardiovascular disease.

Main Results:

  • Statins demonstrate potential for inhibiting cancer cell lines and may offer synergistic effects with existing cancer therapies.
  • Prostate cancer, particularly in older men or those with less aggressive disease, presents a unique opportunity for investigating statins as monotherapy or adjuvant treatment.

Conclusions:

  • Statins represent a promising therapeutic avenue for prostate cancer, potentially impacting both cancer progression and cardiovascular disease, a leading cause of mortality in these patients.
  • Randomized clinical trials are recommended to establish the efficacy of statins as adjuvant therapy or monotherapy in prostate cancer management.

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...